Old Web
English
Sign In
Acemap
>
authorDetail
>
M. José Galindo
M. José Galindo
Medicine
Cohort
Demography
Epidemiology
HIV/AIDS
4
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AB0827 IS DENOSUMAB SAFE IN HIV PATIENTS
2019
Annals of the Rheumatic Diseases
Isabel de la Morena
Sara Vela
Juan Alberto Paz-Solarte
Diego Bedoya
M. José Galindo
Show All
Source
Cite
Save
Citations (0)
Losses to follow-up of HIV-infected people in the Spanish VACH cohort over the period between 2013 and 2014: The importance of sociodemographic factors
2019
Enfermedades Infecciosas Y Microbiologia Clinica
Ramón Teira
Nuria Espinosa
Mar Gutiérrez
Marta Montero
Elisa Martínez
Francisco J. Gonzalez
Fernando Lozano de León
Francisco Téllez
M. José Galindo
Joaquim Peraire
Elisabeth Deig
Pepa Muñoz-Sánchez
Show All
Source
Cite
Save
Citations (1)
Pérdidas de seguimiento de personas con infección por el VIH en la cohorte española VACH en el periodo 2013-2014: importancia de los factores sociodemográficos
2018
Enfermedades Infecciosas Y Microbiologia Clinica
Ramón Teira
Nuria Espinosa
Mar Gutiérrez
Marta Montero
Elisa Martínez
Francisco J. Gonzalez
Fernando Lozano de León
Francisco Tellez
M. José Galindo
Joaquim Peraire
E Deig
Pepa Muñoz-Sánchez
Show All
Source
Cite
Save
Citations (2)
Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort)
2002
AIDS
Ignacio Suárez Lozano
José María Fajardo
Myriam Garrido
Bernardino Roca
M. Luisa Garcia-Alcalde
Paloma Geijo
Daniel Selma
Fernando Lozano
Ramón Teira
Pompeyo Viciana
Salvador Perez-Cortes
Pere Domingo
Antonia Menchero
M. José Galindo
Jaime Cosín
Esteban Ribera
José Ramón Arribas
Juan R. Lacalle
Show All
Source
Cite
Save
Citations (25)
1